These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9330577)

  • 21. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
    Goa KL; Wagstaff AJ
    Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Angiotensin II antagonists: a distinct therapeutic class].
    Waeber B; Brunner HR
    Presse Med; 1996 Oct; 25(32):1533-5. PubMed ID: 8952659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
    Krasnikova TL
    Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin II antagonism: a new avenue of hypertension management.
    Gavras H
    Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
    Zimlichman R
    Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of losartan.
    Goldberg A; Sweet C
    Can J Cardiol; 1995 Aug; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-receptor blocker approved as antihypertensive.
    Am J Health Syst Pharm; 1995 Jul; 52(13):1368, 1373. PubMed ID: 7671033
    [No Abstract]   [Full Text] [Related]  

  • 28. Failure of losartan to control blood pressure in scleroderma renal crisis.
    Caskey FJ; Thacker EJ; Johnston PA; Barnes JN
    Lancet; 1997 Mar; 349(9052):620. PubMed ID: 9057740
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fast-acting sartan. High blood pressure therapy without long waiting time].
    MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866306
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin receptors and their antagonists.
    Goodfriend TL; Elliott ME; Catt KJ
    N Engl J Med; 1996 Jun; 334(25):1649-54. PubMed ID: 8628362
    [No Abstract]   [Full Text] [Related]  

  • 31. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms.
    Opsahl JA; Goldberg MR; Katz SA
    Am J Hypertens; 1995 Nov; 8(11):1090-8. PubMed ID: 8554732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin II receptor antagonists].
    Bornkessel B
    Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful long-term treatment of post-transplant erythrocytosis with losartan.
    Midtvedt K; Stokke ES; Hartmann A
    Nephrol Dial Transplant; 1996 Dec; 11(12):2495-7. PubMed ID: 9017632
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical angiotensin II-receptor blockade in hypertension and heart failure].
    van Zwieten PA; Lie KI
    Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1529-33. PubMed ID: 7675129
    [No Abstract]   [Full Text] [Related]  

  • 36. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
    Burrell LM
    Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist].
    Kjeldsen SE; Omvik P
    Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney.
    Missouris CG; Ward DE; Eastwood JB; MacGregor GA
    Heart; 1997 Apr; 77(4):391-2. PubMed ID: 9155634
    [No Abstract]   [Full Text] [Related]  

  • 39. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 40. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan.
    Bunt T
    Clin Ther; 1999 Mar; 21(3):611-2. PubMed ID: 10321426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.